Literature DB >> 19286908

Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome.

M-A Bouldouyre, P Cohen, L Guillevin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286908     DOI: 10.1136/ard.2008.093773

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Aggressive eosinophilic granulomatosis with polyangiitis and transverse sinus thrombosis.

Authors:  Snegha Ananth; Rajeswari Sankaralingam; Manesh Manoj
Journal:  BMJ Case Rep       Date:  2016-01-12

Review 2.  Kinase inhibitors and monoclonal antibodies in oncology: clinical implications.

Authors:  Helen Gharwan; Hunter Groninger
Journal:  Nat Rev Clin Oncol       Date:  2015-12-31       Impact factor: 66.675

3.  Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.

Authors:  Rodrigo Cartin-Ceba; Karina A Keogh; Ulrich Specks; Sanjeev Sethi; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2011-02-16       Impact factor: 5.992

Review 4.  Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.

Authors:  Loïc Raffray; Loïc Guillevin
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

Review 5.  Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Authors:  David Aguirre-Valencia; Iván Posso-Osorio; Juan-Carlos Bravo; Fabio Bonilla-Abadía; Gabriel J Tobón; Carlos A Cañas
Journal:  Clin Rheumatol       Date:  2017-07-31       Impact factor: 2.980

6.  Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Authors:  Jens Thiel; Fabian Hässler; Ulrich Salzer; Reinhard E Voll; Nils Venhoff
Journal:  Arthritis Res Ther       Date:  2013-09-24       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.